<VariationArchive VariationID="195560" VariationName="NM_000282.4(PCCA):c.1899+4_1899+7del" VariationType="Deletion" Accession="VCV000195560" Version="16" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-06-17" DateCreated="2015-06-28" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="192721" VariationID="195560">
      <GeneList>
        <Gene Symbol="PCCA" FullName="propionyl-CoA carboxylase subunit alpha" GeneID="5095" HGNC_ID="HGNC:8653" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100089093" stop="100530435" display_start="100089093" display_stop="100530435" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100741268" stop="101182690" display_start="100741268" display_stop="101182690" Strand="+" />
          </Location>
          <OMIM>232000</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000282.4(PCCA):c.1899+4_1899+7del</Name>
      <CanonicalSPDI>NC_000013.11:100449305:GTAAGTA:GTA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100449306" stop="100449309" display_start="100449306" display_stop="100449309" variantLength="4" positionVCF="100449305" referenceAlleleVCF="GGTAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="101101560" stop="101101563" display_start="101101560" display_stop="101101563" variantLength="4" positionVCF="101101559" referenceAlleleVCF="GGTAA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.3" sequenceAccession="NM_000282" sequenceVersion="3" change="c.1899+4_1899+7delAGTA">
            <Expression>NM_000282.3:c.1899+4_1899+7delAGTA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.101101563_101101566del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.101101563_101101566del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.100449309_100449312del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.100449309_100449312del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008768.1" sequenceAccession="NG_008768" sequenceVersion="1" change="g.365227_365230del">
            <Expression>NG_008768.1:g.365227_365230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.4" sequenceAccession="NM_000282" sequenceVersion="4" change="c.1899+4_1899+7del" MANESelect="true">
            <Expression>NM_000282.4:c.1899+4_1899+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178004.2" sequenceAccession="NM_001178004" sequenceVersion="2" change="c.1899+4_1899+7del">
            <Expression>NM_001178004.2:c.1899+4_1899+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352605.2" sequenceAccession="NM_001352605" sequenceVersion="2" change="c.1845+23578_1845+23581del">
            <Expression>NM_001352605.2:c.1845+23578_1845+23581del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352606.2" sequenceAccession="NM_001352606" sequenceVersion="2" change="c.1755+4_1755+7del">
            <Expression>NM_001352606.2:c.1755+4_1755+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352610.2" sequenceAccession="NM_001352610" sequenceVersion="2" change="c.954+4_954+7del">
            <Expression>NM_001352610.2:c.954+4_954+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352611.2" sequenceAccession="NM_001352611" sequenceVersion="2" change="c.900+23578_900+23581del">
            <Expression>NM_001352611.2:c.900+23578_900+23581del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352612.2" sequenceAccession="NM_001352612" sequenceVersion="2" change="c.810+4_810+7del">
            <Expression>NM_001352612.2:c.810+4_810+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127692.3" sequenceAccession="NM_001127692" sequenceVersion="3" change="c.1821+4_1821+7del">
            <Expression>NM_001127692.3:c.1821+4_1821+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352607.2" sequenceAccession="NM_001352607" sequenceVersion="2" change="c.1821+4_1821+7del">
            <Expression>NM_001352607.2:c.1821+4_1821+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352608.2" sequenceAccession="NM_001352608" sequenceVersion="2" change="c.1677+4_1677+7del">
            <Expression>NM_001352608.2:c.1677+4_1677+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352609.2" sequenceAccession="NM_001352609" sequenceVersion="2" change="c.1899+4_1899+7del">
            <Expression>NM_001352609.2:c.1899+4_1899+7del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA278506" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="232000.0001" DB="OMIM" />
        <XRef Type="rs" ID="794727334" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 232000.0001 based on the sequence reported in Figure 2 of the paper by Richard et al., 1997 (PubMed 9385377).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000282.4(PCCA):c.1899+4_1899+7del AND not provided" Accession="RCV000176154" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-12-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000282.4(PCCA):c.1899+4_1899+7del AND Propionic acidemia" Accession="RCV001066663" Version="12">
        <ClassifiedConditionList TraitSetID="3247">
          <ClassifiedCondition DB="MedGen" ID="C0268579">Propionic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-30" SubmissionCount="6">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-30" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2015-06-28" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10101253</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10780784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12385775</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15235904</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22033733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23348723</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33473339</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6790853</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9385377</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCCA</URL>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3247" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5805" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
                <XRef ID="Propionic+acidemia/5994" DB="Genetic Alliance" />
                <XRef ID="HP:0003571" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0011628" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycinemia, ketotic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperglycinemia with ketoacidosis and leukopenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ketotic hyperglycinemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PROP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of propionic acidemia (PA) ranges from neonatal-onset to late-onset disease. Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor feeding and decreased arousal in the first few days of life, followed by progressive encephalopathy of unexplained origin. Without prompt diagnosis and management, this is followed by progressive encephalopathy manifesting as lethargy, seizures, or coma that can result in death. It is frequently accompanied by metabolic acidosis with anion gap, lactic acidosis, ketonuria, hypoglycemia, hyperammonemia, and cytopenias. Individuals with late-onset PA may remain asymptomatic and suffer a metabolic crisis under catabolic stress (e.g., illness, surgery, fasting) or may experience a more insidious onset with the development of multiorgan complications including vomiting, protein intolerance, failure to thrive, hypotonia, developmental delays or regression, movement disorders, or cardiomyopathy. Isolated cardiomyopathy can be observed on rare occasion in the absence of clinical metabolic decompensation or neurocognitive deficits. Manifestations of neonatal and late-onset PA over time can include growth impairment, intellectual disability, seizures, basal ganglia lesions, pancreatitis, and cardiomyopathy. Other rarely reported complications include optic atrophy, hearing loss, premature ovarian insufficiency, and chronic renal failure.</Attribute>
                <XRef ID="NBK92946" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="467" />
                <XRef ID="467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22593918</ID>
                <ID Source="BookShelf">NBK92946</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2017">
                <URL>https://managementguidelines.net/guidelines.php/104/PROP%20Nutrition%20Guidelines/Version%201.2</URL>
                <CitationText>PROP Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="35" DB="Orphanet" />
              <XRef ID="C0268579" DB="MedGen" />
              <XRef ID="MONDO:0011628" DB="MONDO" />
              <XRef Type="MIM" ID="606054" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003571" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="416081" SubmissionDate="2018-09-19" DateLastUpdated="2015-06-28" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="25570_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000227764" DateUpdated="2015-06-28" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10780784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12385775</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15235904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9385377</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="-" referenceAllele="AGTA" start="101101563" stop="101101566" variantLength="4" />
            <GeneLocation>NM_000282.3:IVS21</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD972377" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCCA</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878968" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_000282.3:c.1899+4_1899+7del|PROPIONIC ACIDEMIA" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984842" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant is a 4 bp deletion starting at position +4 of intron 21 of the PCCA gene and is predicted to affect native splicing by in-silico tools. This variant, named 1824IVS+3del4, has been previously reported as a homozygous change in an individual with propionic acidemia and moderate psychomotor delay (PMID: 10780784, 9385377). The PCC enzyme activity in the patient's fibroblasts was significantly lower than the normal control (PMID: 10780784). The c.1899+4_1899+7del is also reported in the literature as IVS21+3del4 (PMID: 15235904). Splicing studies in patient's fibroblasts demonstrated that this variant leads to skipping of exon 21 and residual low levels of normal splicing (PMID: 9385377, 15235904). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.0059% (9/152424) and thus is presumed to be rare. Based on the available evidence, the c.1899+4_1899+7del variant is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.1899+4_1899+7del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROPIONIC ACIDEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10524990</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="33040" SubmissionDate="2021-12-20" DateLastUpdated="2021-12-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="232000.0001_PROPIONIC ACIDEMIA" title="PCCA, 4-BP DEL, 1824IVS, +3_PROPIONIC ACIDEMIA" />
        <ClinVarAccession Accession="SCV000033040" DateUpdated="2021-12-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Richard et al. (1997) identified a 4-bp (AAGT) deletion in the intron downstream from nucleotide 1824 in the PCCA gene in an 18-year-old patient with a late-onset, relatively mild form of propionic acidemia (606054) reported by Merinero et al. (1981). The diagnosis was made at the age of 17 months. The patient demonstrated a favorable response to restriction of dietary protein, and psychomotor development was adequate. The mutation was present in homozygous form.</Attribute>
              <Citation>
                <ID Source="PubMed">9385377</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">6790853</ID>
              </Citation>
              <XRef DB="OMIM" ID="606054" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Clavero et al. (2004) performed mRNA analysis of a fibroblast cell line from the patient reported by Richard et al. (1997) to test for the presence of normally spliced transcripts which might explain the patient's mild phenotype. Very low levels of normal-sized transcript were detectable by ethidium bromide staining; quantitative RT-PCR revealed 30-fold less correctly spliced PCCA mRNA in the patient's fibroblasts than in normal control fibroblasts. Clavero et al. (2004) suggested that very low levels of correctly spliced transcript are sufficient to permit development of the mild phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">15235904</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9385377</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <Name>PCCA, 4-BP DEL, 1824IVS, +3</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 1824IVS, +3</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="232000.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROPIONIC ACIDEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7852805" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000282.4:c.1899+4_1899+7del|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004202841" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.4:c.1899+4_1899+7del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2827726" SubmissionDate="2022-07-29" DateLastUpdated="2022-08-03" DateCreated="2020-09-14">
        <ClinVarSubmissionID localKey="NM_000282.3:c.1899+4_1899+7delAGTA|MedGen:C0268579" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001431999" DateUpdated="2022-08-03" DateCreated="2020-09-14" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23348723</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10780784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22033733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10101253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15235904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9385377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33473339</ID>
          </Citation>
          <Comment>Variant summary: PCCA c.1899+4_1899+7delAGTA alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. At least one publication reports experimental evidence that this variant affects mRNA splicing. In functional studies, the variant resulted in an in-frame deletion of 18 amino acids as a result of exon skipping (Richard_1997, Clavero_2004). It was also reported that small levels of (3-16%) of correctly spliced transcript were found in a homozygous patient, which was sufficient to permit the development of a mild phenotype (Clavero_2004). The variant allele was found at a frequency of 5.9e-05 in 152424 control chromosomes (gnomAD). c.1899+4_1899+7delAGTA has been reported in the literature in multiple individuals affected with Propionic Acidemia (Richard_1997, Kraus_2012, Stanescu_2021). These data indicate that the variant is very likely to be associated with disease. Two assessments for this variant have been submitted to ClinVar after 2014. One submitter classified the variant as pathogenic and the other classified it as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.1899+4_1899+7delAGTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268579" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11876943</SubmissionName>
          <SubmissionName>SUB8118025</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464764" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000282.4:c.1899+4_1899+7del|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002807372" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.4:c.1899+4_1899+7del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2397280" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="1213733|MedGen:C0268579" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001231679" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9385377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10101253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10780784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22033733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9385377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15235904</ID>
          </Citation>
          <Comment>This sequence change falls in intron 21 of the PCCA gene. It does not directly change the encoded amino acid sequence of the PCCA protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs794727334, gnomAD 0.03%). This variant has been observed in individual(s) with propionic acidemia (PMID: 9385377, 10101253, 10780784, 22033733). This variant is also known as 1824IVS+3del4 and IVS21+3del4. ClinVar contains an entry for this variant (Variation ID: 195560). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of 21, but is expected to preserve the integrity of the reading-frame (PMID: 9385377, 15235904). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.101101560_101101563del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268579" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7852805" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2827726" TraitType="Disease" MappingType="XRef" MappingValue="C0268579" MappingRef="MedGen">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464764" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878968" TraitType="Disease" MappingType="Name" MappingValue="PROPIONIC ACIDEMIA" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2397280" TraitType="Disease" MappingType="XRef" MappingValue="C0268579" MappingRef="MedGen">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="416081" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="33040" TraitType="Disease" MappingType="Name" MappingValue="PROPIONIC ACIDEMIA" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

